Cynthia D.

Cynthia D. currently serves as the Director of Forecasting & Analytics at ONO PHARMA USA, INC. since September 2022. Prior to this role, Cynthia held positions at Biogen as Director of US Forecasting, leading a team in forecasting and supporting business planning across various therapeutic areas. During tenure at EMD Serono, Cynthia worked as Associate Director of Forecasting & Performance Metrics, overseeing forecasting efforts for multiple therapeutic areas and preparing for the launch of Mavenclad. At Eisai US, Cynthia progressed from Associate Director to Director in both Market Research and Forecasting, contributing significantly to oncology products and collaborating closely with finance and other departments. Earlier in the career, Cynthia worked at Ligand Pharmaceuticals as Director of Market Research, focusing on oncology and pain therapeutics. Cynthia D. holds an MBA in Marketing from the University of California, Berkeley, Haas School of Business, and a BS in Biological Sciences from the University of California, Davis.